Published in Br J Pharmacol on June 01, 1997
Attenuation of BPDE-induced p53 accumulation by TPA is associated with a decrease in stability and phosphorylation of p53 and downregulation of NFkappaB activation: role of p38 MAP kinase. Carcinogenesis (2005) 0.82
Phenolic fraction of tobacco smoke inhibits BPDE-induced apoptosis response and potentiates cell transformation: role of attenuation of p53 response. Chem Res Toxicol (2011) 0.78
Cacospongionolide and scalaradial, two marine sesterterpenoids as potent apoptosis-inducing factors in human carcinoma cell lines. PLoS One (2012) 0.78
Nitric oxide and its congeners in mitochondria: implications for apoptosis. Environ Health Perspect (1998) 0.77
Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J Biol Chem (1992) 2.03
Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem (1992) 1.60
Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment. J Biol Chem (1996) 1.58
Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem (1999) 1.56
Accumulation of HIF-1alpha under the influence of nitric oxide. Blood (2001) 1.55
Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. Biochem J (1996) 1.50
p53 expression in nitric oxide-induced apoptosis. FEBS Lett (1994) 1.42
NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol Biol Cell (1999) 1.33
Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res (1994) 1.28
Mechanism of covalent modification of glyceraldehyde-3-phosphate dehydrogenase at its active site thiol by nitric oxide, peroxynitrite and related nitrosating agents. FEBS Lett (1994) 1.28
Extracellular ATP causes apoptosis and necrosis of cultured mesangial cells via P2Z/P2X7 receptors. Am J Physiol (1998) 1.28
Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. J Biol Chem (2001) 1.24
Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J Biol Chem (1996) 1.23
Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3K pathway. Biochem Biophys Res Commun (2000) 1.18
Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem Biophys Res Commun (1997) 1.14
Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J Biol Chem (1999) 1.12
Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol Pharmacol (1995) 1.09
Cyclooxygenase-2: an essential regulator of NO-mediated apoptosis. FASEB J (1997) 1.05
Nitric oxide induced poly(ADP-ribose) polymerase cleavage in RAW 264.7 macrophage apoptosis is blocked by Bcl-2. FEBS Lett (1996) 1.05
Mass spectrometric analysis of nitric oxide-modified caspase-3. J Biol Chem (1999) 1.04
Delayed activation of PPARgamma by LPS and IFN-gamma attenuates the oxidative burst in macrophages. FASEB J (2001) 1.03
Etoposide and cisplatin induced apoptosis in activated RAW 264.7 macrophages is attenuated by cAMP-induced gene expression. Oncogene (1998) 1.02
Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression. J Immunol (1999) 0.99
Recognition of apoptotic cells by macrophages activates the peroxisome proliferator-activated receptor-gamma and attenuates the oxidative burst. Cell Death Differ (2005) 0.98
Nitric oxide (NO) in apoptotic versus necrotic RAW 264.7 macrophage cell death: the role of NO-donor exposure, NAD+ content, and p53 accumulation. Arch Biochem Biophys (1996) 0.98
Exogenous nitric oxide (NO) generation or IL-1 beta-induced intracellular NO production stimulates inhibitory auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase in RINm5F cells. J Immunol (1993) 0.98
Mechanisms for nitric oxide-induced cell death: involvement of apoptosis. Adv Neuroimmunol (1995) 0.96
Nitric oxide donors induce apoptosis in glomerular mesangial cells, epithelial cells and endothelial cells. Eur J Pharmacol (1996) 0.96
Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis. Biochemistry (1999) 0.95
Low-molecular-weight hyaluronic acid induces nuclear factor-kappaB-dependent resistance against tumor necrosis factor alpha-mediated liver injury in mice. Hepatology (2001) 0.93
Hypoxia and HIF-1alpha protect A549 cells from drug-induced apoptosis. Cell Death Differ (2006) 0.93
The balance between nitric oxide and superoxide determines apoptotic and necrotic death of rat mesangial cells. J Immunol (1997) 0.92
Overexpression of CuZn superoxide dismutase protects RAW 264.7 macrophages against nitric oxide cytotoxicity. Biochem J (1999) 0.92
Nitric oxide and superoxide inhibit platelet-derived growth factor receptor phosphotyrosine phosphatases. Free Radic Biol Med (1999) 0.91
U937 apoptotic cell death by nitric oxide: Bcl-2 downregulation and caspase activation. Exp Cell Res (1998) 0.90
Superoxide and nitric oxide--participation in cell communication. Cell Death Differ (2002) 0.90
p53 accumulation in apoptotic macrophages is an energy demanding process that precedes cytochrome c release in response to nitric oxide. Oncogene (1999) 0.88
Characterization of a nitric-oxide-catalysed ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Eur J Biochem (1992) 0.87
Reversible activation of soluble guanylate cyclase by oxidizing agents. Arch Biochem Biophys (1992) 0.86
Attenuation of macrophage apoptosis by the cAMP-signaling system. Mol Cell Biochem (2000) 0.86
Endotoxic shock leads to apoptosis in vivo and reduces Bcl-2. Shock (1996) 0.86
Heat shock proteins and macrophage resistance to the toxic effects of nitric oxide. Biochem J (1996) 0.86
Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int (1997) 0.85
Apoptosis is triggered by the cyclic AMP signalling pathway in renal mesangial cells. FEBS Lett (1996) 0.85
Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: the role of cyclic GMP and tyrosine phosphatase inhibition. J Immunol (1998) 0.84
The sulfhydryl reagent thimerosal elicits human platelet aggregation by mobilization of intracellular calcium and secondary prostaglandin endoperoxide formation. Biochem Biophys Res Commun (1989) 0.84
L-arginine stimulates an endogenous ADP-ribosyltransferase. Biochem Biophys Res Commun (1991) 0.83
The dual role of S-nitrosoglutathione (GSNO) during thymocyte apoptosis. Cell Signal (1996) 0.82
The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages. Oncogene (2012) 0.82
Protease activation during nitric oxide-induced apoptosis: comparison between poly(ADP-ribose) polymerase and U1-70kDa cleavage. Eur J Pharmacol (1998) 0.82
Modification of macrophage glyceraldehyde-3-phosphate dehydrogenase in response to nitric oxide. Eur J Pharmacol (1996) 0.82
Redox regulation in acute and chronic inflammation. Cell Death Differ (2009) 0.81
Nitric oxide preferentially stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase compared to alcohol or lactate dehydrogenase. FEBS Lett (1993) 0.81
Wortmannin interferes with thrombin-evoked secondary calcium redistribution in human platelets. Cell Signal (1997) 0.81
NO-Evoked macrophage apoptosis is attenuated by cAMP-induced gene expression. Mol Med (1999) 0.80
Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21(WAF1/CIP1). J Leukoc Biol (2000) 0.80
The interaction of superoxide with nitric oxide destabilizes hypoxia-inducible factor-1alpha. Cell Mol Life Sci (2007) 0.80
Nitrosative and oxidative stress induced heme oxygenase-1 accumulation in rat mesangial cells. Eur J Pharmacol (1998) 0.79
Up-regulation of Bcl-2 by redox signals in glomerular mesangial cells. Cell Death Differ (2000) 0.78
Ebselen prevents inositol (1,4,5)-trisphosphate binding to its receptor. Biochem Pharmacol (1991) 0.78
Protection against nitric oxide-induced apoptosis in rat mesangial cells demands mitogen-activated protein kinases and reduced glutathione. Mol Pharmacol (1999) 0.78
Modulation of inducible nitric oxide synthase in RINm5F cells. Cell Signal (1994) 0.78
Apoptosis and expression of inducible nitric oxide synthase are mutually exclusive in renal mesangial cells. Am J Pathol (1997) 0.77
Efflux of cyclic GMP from activated human platelets. Mol Pharmacol (1993) 0.77
Superinduction of cyclooxygenase-2 by NO(*) and agonist challenge involves transcriptional regulation mediated by AP-1 activation. Biochemistry (2000) 0.77
Nitric oxide-induced F-actin disassembly is mediated via cGMP, cAMP, and protein kinase A activation in rat mesangial cells. Exp Cell Res (2001) 0.77
Redox regulation and the metabolic syndrome. Cell Death Differ (2011) 0.76
Activation of PPARgamma is not involved in butyrate-induced epithelial cell differentiation. Exp Cell Res (2005) 0.76
Physiological targets of superoxide anion and hydrogen peroxide in reperfusion injury. Free Radic Res Commun (1989) 0.75
Molecular actions of nitric oxide in mesangial cells. Histol Histopathol (2000) 0.75
Modulation of glyceraldehyde-3-phosphate dehydrogenase in Salmonella abortus equi lipopolysaccharide-treated mice. Eur J Pharmacol (1994) 0.75
Calabria: sun, sand, and cell death. Cell Death Differ (2002) 0.75
Redox regulation by ischemia/reperfusion. Cell Death Differ (2006) 0.75